medigraphic.com
ISSN 0016-3813 (Print)

2012, Number 2

<< Back Next >>

Gac Med Mex 2012; 148 (2)

Denervación simpática renal (DSR): una nueva terapéutica no farmacológica para la hipertensión arterial (HTA ) resistente. Informe del primer procedimiento en México

Gaspar HJ, Eid-Lidt G, Payró RG, Ricalde AA, Martínez RMA

Language: Spanish
References: 18
Page: 125-129
PDF size: 767.38 Kb.


ABSTRACT

A patient with resistant hypertension successfully treated with sympathetic renal denervation (SRD) is reported. This novel therapy is based on the partial ablation of the renal nerves by applying radiofrequency to the luminal surface of the renal arteries using vascular catheterization techniques. This first case performed in Mexico has two particular features: (i) an electrophysiology ablation catheter was employed due to the unavailability of the system specifically designed for SDR, and (ii) under current denervation protocols, the anatomical complexity of the targeted renal arteries would have excluded our patient from this procedure and thus deprived her of the benefit provided.


REFERENCES

  1. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol. 2008;52:1749-57.

  2. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-19.

  3. Chobanian A, Bakris G, Black H. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.

  4. Katholi RE. Renal nerves and hypertension: an update. Fed Proc. 1985;44:2846-50.

  5. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-81.

  6. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911-7.

  7. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therpaeutic approach for hypertension. Novel Implications for an old concept. Hypertension. 2009;54:1195-201.

  8. Socas A, Hernández Madrid A, González Rebollo JM, et al. Estudio de las características anatomopatológicas y la seguridad de las lesiones producidas en la aurícula con dos diferentes sistemas de catéteres de punta irrigada en un modelo experimental. Rev Esp Cardiol. 2001:54:1283-6.

  9. Barquera S, Campos-Nonato I, Hernández-Barrera L, et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Pública Mex. 2010;52:63-71.

  10. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol. 2008;52:1749-57.

  11. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-19.

  12. Chobanian A, Bakris G, Black H. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.

  13. Katholi RE. Renal nerves and hypertension: an update. Fed Proc. 1985;44:2846-50.

  14. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-81.

  15. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911-7.

  16. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therpaeutic approach for hypertension. Novel Implications for an old concept. Hypertension. 2009;54:1195-201.

  17. Socas A, Hernández Madrid A, González Rebollo JM, et al. Estudio de las características anatomopatológicas y la seguridad de las lesiones producidas en la aurícula con dos diferentes sistemas de catéteres de punta irrigada en un modelo experimental. Rev Esp Cardiol. 2001:54:1283-6.

  18. Barquera S, Campos-Nonato I, Hernández-Barrera L, et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Pública Mex. 2010;52:63-71.




2020     |     www.medigraphic.com